We are live on ! Find out more
JSP

Jackson Square Partners Portfolio holdings

AUM $247M
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
+9.97%
1 Year Est. Return
+20.29%
3 Year Est. Return
+101.87%
5 Year Est. Return
+75.18%
10 Year Est. Return
+392.81%
AUM
$21.4B
AUM Growth
+$1.44B
Cap. Flow
-$491M
Cap. Flow %
-2.3%
Top 10 Hldgs %
35.67%
Holding
94
New
5
Increased
29
Reduced
48
Closed
8

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$469M
2
MTCH icon
Match Group
MTCH
+$337M
3
WIX icon
WIX.com
WIX
+$158M
4
PLAN
Anaplan, Inc.
PLAN
+$139M
5
PAYC icon
Paycom
PAYC
+$101M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$410M
2
IQV icon
IQVIA
IQV
+$232M
3
MSFT icon
Microsoft
MSFT
+$214M
4
HAE icon
Haemonetics
HAE
+$206M
5
CME icon
CME Group
CME
+$187M

Sector Composition

Rank Sector Weight
1 Technology 34.26%
2 Consumer Discretionary 14.01%
3 Financials 13.56%
4 Communication Services 13.23%
5 Healthcare 12.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COUP
26
DELISTED
Coupa Software Incorporated
COUP
$369M 1.73%
1,347,058
-102,931
-7% -$30M
RAMP icon
27
LiveRamp
RAMP
$2.3B
$298M 1.4%
5,764,842
-989,212
-15% -$49.5M
SBUX icon
28
Starbucks
SBUX
$119B
$297M 1.39%
3,456,967
-151,500
-4% -$12.1M
GO icon
29
Grocery Outlet
GO
$1.23B
$293M 1.37%
7,446,547
-433,917
-6% -$17.9M
FTCH
30
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$265M 1.24%
10,525,934
-1,045,825
-9% -$25.9M
GWRE icon
31
Guidewire Software
GWRE
$13.5B
$260M 1.21%
2,489,815
+66,081
+3% +$7.42M
GLIBA
32
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$245M 1.15%
2,988,761
-90,647
-3% -$7.15M
TECH icon
33
Bio-Techne
TECH
$11.4B
$245M 1.14%
3,948,772
-42,988
-1% -$2.8M
ESTC icon
34
Elastic
ESTC
$9.64B
$238M 1.11%
2,207,410
-51,651
-2% -$5.07M
PZZA icon
35
Papa John's
PZZA
$747M
$219M 1.02%
2,656,458
-315,244
-11% -$28.9M
VRNS icon
36
Varonis Systems
VRNS
$5.29B
$211M 0.99%
5,497,206
-138,291
-2% -$5.16M
SFIX
37
Stitch Fix
SFIX
$407M
$208M 0.97%
7,672,702
+211,902
+3% +$5.44M
BILL icon
38
BILL Holdings
BILL
$4.19B
$178M 0.83%
1,770,301
-64,773
-4% -$5.89M
HQY icon
39
HealthEquity
HQY
$7.95B
$170M 0.79%
3,299,782
+1,247,824
+61% +$68.5M
PLAN
40
DELISTED
Anaplan, Inc.
PLAN
$168M 0.79%
+2,689,807
New +$139M
ABMD
41
DELISTED
Abiomed Inc
ABMD
$166M 0.78%
599,704
-14,245
-2% -$4.1M
SAIL
42
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$160M 0.75%
4,048,536
-347,263
-8% -$12.1M
DNKN
43
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$154M 0.72%
1,881,732
-66,381
-3% -$4.79M
RDFN
44
DELISTED
Redfin
RDFN
$151M 0.71%
3,029,939
-36,362
-1% -$1.61M
EQC
45
DELISTED
Equity Commonwealth
EQC
$147M 0.69%
5,511,443
-60,452
-1% -$1.87M
GGG icon
46
Graco
GGG
$12.6B
$145M 0.68%
2,363,692
-27,159
-1% -$1.52M
LOGI icon
47
Logitech
LOGI
$14.6B
$144M 0.68%
1,857,518
-26,408
-1% -$1.89M
NVRO
48
DELISTED
NEVRO CORP.
NVRO
$143M 0.67%
1,028,513
-38,087
-4% -$5.09M
WH icon
49
Wyndham Hotels & Resorts
WH
$5.33B
$140M 0.65%
2,765,424
-77,135
-3% -$3.77M
LYFT icon
50
Lyft
LYFT
$6.33B
$135M 0.63%
4,916,408
+983,228
+25% +$29.2M

Similar funds

Jackson Square Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Jackson Square Partners held 94 positions worth $21.4B, up 7.2% from $19.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Jackson Square Partners's Q3 2020 filing shows 5 new, 29 increased, 48 reduced and 8 closed positions. Its largest new stake was Edwards Lifesciences: 6,016,819 shares worth $480M. The largest sale was UnitedHealth, an estimated $410M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jackson Square Partners's largest Q3 2020 buy was Edwards Lifesciences: 6,016,819 shares worth $480M.
  • Jackson Square Partners added most to Match Group in Q3 2020, an estimated $337M increase.
  • Jackson Square Partners's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $410M.
  • Jackson Square Partners fully exited Haemonetics in Q3 2020, selling an estimated $206M.
  • Jackson Square Partners's ten largest holdings make up 36% of its $21.4B portfolio in Q3 2020.
  • Jackson Square Partners opened 5 new positions and closed 8 in Q3 2020.
  • Jackson Square Partners's portfolio value rose 7.2% quarter-over-quarter to $21.4B.

Based on Jackson Square Partners's 13F filing for Q3 2020, filed 13 Nov 2020.